Wirtschaftsnachrichten (Symbolbild).
Quelle: - pixabay.com:
Google
PR Newswire  | 

Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights

PR Newswire

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
Adverum Biotechnologies Inc 3,50 € Adverum Biotechnologies Inc Chart -1,69%
Zugehörige Wertpapiere:
Barinthus Biotherapeutics plc 0,695 € Barinthus Biotherapeutics plc Chart 0,00%
Zugehörige Wertpapiere:
Fifth Third Bancorp 38,38 € Fifth Third Bancorp Chart 0,00%
Zugehörige Wertpapiere:
Huntington Bancshares Inc 14,654 € Huntington Bancshares Inc Chart 0,00%
Zugehörige Wertpapiere:

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

NEW YORK, Nov. 19, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Barinthus Biotherapeutics plc (NASDAQ: BRNS)'s  merger with Clywedog Therapeutics, Inc. Under the terms of the agreement, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depositary Share or ordinary share owned. If you are a Barinthus shareholder, click here to learn more about your rights and options.

Fifth Third Bancorp (NASDAQ: FITB)'s  merger with Comerica Incorporated. Upon closing of the proposed transaction, Fifth Third shareholders will own approximately 73% of the combined company. If you are a Fifth Third shareholder, click here to learn more about your legal rights and options.

Adverum Biotechnologies, Inc. (NASDAQ: ADVM)'s  sale to Eli Lilly and Company. Under the terms of the proposed transaction, Adverum shareholders will receive $3.56 per share in cash plus one non-transferrable contingent value right (CVR) entitling the holder to receive up to an additional $8.91 per CVR in cash upon the achievement of two certain milestones. If you are an Adverum shareholder, click here to learn more about your rights and options.

Huntington Bancshares Incorporated (NASDAQ: HBAN)'s merger with Cadence Bank. If you are a Huntington shareholder, click here to learn more about your legal rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-brns-fitb-advm-hban-shareholders-to-contact-the-firm-to-discuss-their-rights-302620950.html

SOURCE Halper Sadeh LLP


Für dich aus unserer Redaktion zusammengestellt

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend